SCHEMBL9896151

SCHEMBL9896151

COc1ccc(-c2ncnc3c(C(=O)NC4CCC(NC(=O)O)CC4)c(C)[nH]c23)c(OCC2CC2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 3/20 0.38
GRIN2B Q13224 3/20 0.38
CRHR1 P34998 2/20 0.37
CRHR2 Q13324 2/20 0.37
RIPK2 O43353 2/20 0.36
KDM4E B2RXH2 1/20 0.36
RAB9A P51151 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
HPGDS O60760 3/20 0.34
PAK1 Q13153 1/20 0.34
PRKACA P17612 1/20 0.34
PRKACG P22612 1/20 0.34
PRKACB P22694 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9897220 1.00 GRIN1 (0.38) GRIN1GRIN2BCRHR1CRHR2RIPK2
SCHEMBL9896147 1.00 GRIN1 (0.38) GRIN1GRIN2BCRHR1CRHR2RIPK2
SCHEMBL9898024 0.94 CYP4F2 (0.39) GRIN1GRIN2BCRHR1CRHR2RIPK2
SCHEMBL9896255 0.94 CYP4F2 (0.39) GRIN1GRIN2BCRHR1CRHR2RIPK2
SCHEMBL9896257 0.94 CYP4F2 (0.39) GRIN1GRIN2BCRHR1CRHR2RIPK2
SCHEMBL1440204 0.94 KMT2A (0.39) GRIN1GRIN2BCRHR1CRHR2RIPK2
SCHEMBL9899063 0.94 KMT2A (0.39) GRIN1GRIN2BCRHR1CRHR2RIPK2
SCHEMBL1440212 0.94 KMT2A (0.39) GRIN1GRIN2BCRHR1CRHR2RIPK2
Hydrochloric Acid SCHEMBL9897043 0.93 BTK (0.37) GRIN1GRIN2BCRHR1CRHR2RIPK2
Hydrochloric Acid SCHEMBL9897483 0.93 BTK (0.37) GRIN1GRIN2BCRHR1CRHR2RIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9376442-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2016-06-28 US claimed
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES ASTRAZENECA AB (SE) 2015-03-12 US claimed
US-8927557-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2015-01-06 US claimed
EP-2470536-B1 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2014-11-12 EP claimed
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-14 US claimed
US-9376442-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2016-06-28 US disclosed
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES ASTRAZENECA AB (SE) 2015-03-12 US disclosed
US-8927557-B2 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2015-01-06 US disclosed
EP-2470536-B1 Methylpyrrolopyrimidinecarboxamides TAKEDA GMBH (DE) 2014-11-12 EP disclosed
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES NYCOMED GMBH (DE) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149721-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES PDE5A, PDE12, PDE4A GRIN1 2957/4885GRIN2B 2922/4885CRHR1 3405/4885
US-20150073001-A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES PDE12, PDE5A, PDE4A GRIN1 4046/4885GRIN2B 4241/4885CRHR1 3977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.